BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28937220)

  • 21. Selective Targeting of the Interconversion between Glucosylceramide and Ceramide by Scaffold Tailoring of Iminosugar Inhibitors.
    Baudoin-Dehoux C; Castellan T; Rodriguez F; Rives A; Stauffert F; Garcia V; Levade T; Compain P; Génisson Y
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30669468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
    Désiré J; Mondon M; Fontelle N; Nakagawa S; Hirokami Y; Adachi I; Iwaki R; Fleet GW; Alonzi DS; Twigg G; Butters TD; Bertrand J; Cendret V; Becq F; Norez C; Marrot J; Kato A; Blériot Y
    Org Biomol Chem; 2014 Nov; 12(44):8977-96. PubMed ID: 25277226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Geminal disubstituted pyrrolidine iminosugars and their C-4-fluoro analogues: Synthesis, glycosidase inhibition and molecular docking studies.
    Gavale KS; Chavan SR; Kumbhar N; Kawade S; Doshi P; Khan A; Dhavale DD
    Bioorg Med Chem; 2017 Oct; 25(19):5148-5159. PubMed ID: 28751199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-Alkyl 5-membered ring imino sugars as new potent cytotoxic glucosylceramide synthase inhibitors.
    Faugeroux V; Génisson Y; Andrieu-Abadie N; Colié S; Levade T; Baltas M
    Org Biomol Chem; 2006 Dec; 4(24):4437-9. PubMed ID: 17268635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High β-glucosidase (GBA) activity not attributable to GBA1 and GBA2 in live normal and enzyme-deficient fibroblasts may emphasise the role of additional GBAs.
    Harzer K; Yildiz Y
    Biol Chem; 2015 Nov; 396(11):1241-6. PubMed ID: 25996484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of multimeric pyrrolidine iminosugar inhibitors of human β-glucocerebrosidase and α-galactosidase A: First example of a multivalent enzyme activity enhancer for Fabry disease.
    Martínez-Bailén M; Carmona AT; Cardona F; Matassini C; Goti A; Kubo M; Kato A; Robina I; Moreno-Vargas AJ
    Eur J Med Chem; 2020 Apr; 192():112173. PubMed ID: 32146376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocerebrosidase inhibitors for the treatment of Gaucher disease.
    Trapero A; Llebaria A
    Future Med Chem; 2013 Apr; 5(5):573-90. PubMed ID: 23573974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis of the inhibition of GH1 β-glucosidases by multivalent pyrrolidine iminosugars.
    Martínez-Bailén M; Jiménez-Ortega E; Carmona AT; Robina I; Sanz-Aparicio J; Talens-Perales D; Polaina J; Matassini C; Cardona F; Moreno-Vargas AJ
    Bioorg Chem; 2019 Aug; 89():103026. PubMed ID: 31226649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gluco-1 H-imidazole: A New Class of Azole-Type β-Glucosidase Inhibitor.
    Schröder SP; Wu L; Artola M; Hansen T; Offen WA; Ferraz MJ; Li KY; Aerts JMFG; van der Marel GA; Codée JDC; Davies GJ; Overkleeft HS
    J Am Chem Soc; 2018 Apr; 140(15):5045-5048. PubMed ID: 29601200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A substrate-free activity-based protein profiling screen for the discovery of selective PREPL inhibitors.
    Lone AM; Bachovchin DA; Westwood DB; Speers AE; Spicer TP; Fernandez-Vega V; Chase P; Hodder PS; Rosen H; Cravatt BF; Saghatelian A
    J Am Chem Soc; 2011 Aug; 133(30):11665-74. PubMed ID: 21692504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Expression of Human Glucosylceramidase 2 Isoforms on Lipid Profiles in COS-7 Cells.
    Jatooratthawichot P; Talabnin C; Ngiwsara L; Rustam YH; Svasti J; Reid GE; Ketudat Cairns JR
    Metabolites; 2020 Nov; 10(12):. PubMed ID: 33261081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring substituent diversity on pyrrolidine-aryltriazole iminosugars: Structural basis of β-glucocerebrosidase inhibition.
    Martínez-Bailén M; Carmona AT; Patterson-Orazem AC; Lieberman RL; Ide D; Kubo M; Kato A; Robina I; Moreno-Vargas AJ
    Bioorg Chem; 2019 May; 86():652-664. PubMed ID: 30825709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence polarisation activity-based protein profiling for the identification of deoxynojirimycin-type inhibitors selective for lysosomal retaining alpha- and beta-glucosidases.
    van der Gracht D; Rowland RJ; Roig-Zamboni V; Ferraz MJ; Louwerse M; Geurink PP; Aerts JMFG; Sulzenbacher G; Davies GJ; Overkleeft HS; Artola M
    Chem Sci; 2023 Aug; 14(34):9136-9144. PubMed ID: 37655021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1.
    Akiyama H; Kobayashi S; Hirabayashi Y; Murakami-Murofushi K
    Biochem Biophys Res Commun; 2013 Nov; 441(4):838-43. PubMed ID: 24211208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid modifications of N-substitution in iminosugars: development of new β-glucocerebrosidase inhibitors and pharmacological chaperones for Gaucher disease.
    Cheng WC; Weng CY; Yun WY; Chang SY; Lin YC; Tsai FJ; Huang FY; Chen YR
    Bioorg Med Chem; 2013 Sep; 21(17):5021-8. PubMed ID: 23880081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes.
    Burke DG; Rahim AA; Waddington SN; Karlsson S; Enquist I; Bhatia K; Mehta A; Vellodi A; Heales S
    J Inherit Metab Dis; 2013 Sep; 36(5):869-72. PubMed ID: 23151684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity-Based Probes for Glycosidases: Profiling and Other Applications.
    Kuo CL; van Meel E; Kytidou K; Kallemeijn WW; Witte M; Overkleeft HS; Artola ME; Aerts JM
    Methods Enzymol; 2018; 598():217-235. PubMed ID: 29306436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycosidase profiling with immobilised glycosidase-inhibiting iminoalditols--a proof-of-concept study.
    Steiner AJ; Stütz AE; Wrodnigg TM; Tarling CA; Withers SG; Hermetter A; Schmidinger H
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1922-5. PubMed ID: 18281216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease.
    Ashe KM; Bangari D; Li L; Cabrera-Salazar MA; Bercury SD; Nietupski JB; Cooper CG; Aerts JM; Lee ER; Copeland DP; Cheng SH; Scheule RK; Marshall J
    PLoS One; 2011; 6(6):e21758. PubMed ID: 21738789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CuAAC click chemistry with N-propargyl 1,5-dideoxy-1,5-imino-D-gulitol and N-propargyl 1,6-dideoxy-1,6-imino-D-mannitol provides access to triazole-linked piperidine and azepane pseudo-disaccharide iminosugars displaying glycosidase inhibitory properties.
    Zamoner LO; Aragão-Leoneti V; Mantoani SP; Rugen MD; Nepogodiev SA; Field RA; Carvalho I
    Carbohydr Res; 2016 Jun; 429():29-37. PubMed ID: 27160849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.